JBPOS0101
JBPOS0101 Uses, Dosage, Side Effects, Food Interaction and all others data.
JBPOS0101 is under investigation in clinical trial NCT03976076 (A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients).
| Trade Name | JBPOS0101 |
| Generic | JBPOS0101 |
| Type | |
| Formula | C10H12ClNO3 |
| Weight | Average: 229.66 Monoisotopic: 229.050571 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here JBPOS0101
